Why Broker Submissions That Cannot Be Compared Can Destroy Profitable Growth

The Hidden Profitability Drain of Incomparable Submission Data

Broker submissions that cannot be compared can destroy profitable growth because growth that is built on risk-selection decisions made without comparable data adds premium to the portfolio whose risk quality has not been assessed on the same basis as the existing portfolio, and whose pricing has not been calibrated against comparable risks from other brokers. The new business appears to contribute margin at the target combined ratio—the pricing model produced a technical price based on the submission data, and the technical price met the target—but the submission data was non-standard, the exposure was defined differently, the loss history was presented incompletely, and the pricing model's output was based on an input that did not describe the same risk as a standard submission would have. The growth appears profitable at the point of underwriting. The loss ratio that develops will reveal that the growth was not profitable, and the return on the capital deployed to fund the growth will be below the target. For CFOs, CUOs, and underwriting-performance analysts, incomparable submissions are a growth-quality problem: they fund growth whose profitability the inconsistent data has inflated.

Why does the profitability impact of incomparable submissions matter more now?

The profitability impact matters more now because the hardening market is increasing the premium available for growth, and the temptation to grow by accepting non-standard submissions is rising. When capacity is constrained and cedents are seeking coverage, brokers may submit risks in whatever format is fastest, and the reinsurer that does not enforce a submission standard may accept business whose data quality does not support the risk-selection decision. The enterprise risk framework that governs the portfolio's profitability depends on the data quality at the point of selection.

The second reason is the capital-allocation consequence: the CFO allocates capital to lines based on their expected return, and if the expected return for the growth segments is based on the pricing model's output—which used non-standard submission data—the expected return is overstated. The capital allocated to fund the growth earns a below-target return, and the aggregate ROE is reduced. The solvency relief that reinsurance provides is eroded by growth whose profitability the submission data has inflated.

The third reason is the compounding effect: as the growth funded by non-standard submissions accumulates, the portfolio's overall loss ratio rises, and the CUO's response—to tighten the underwriting guidelines, to increase the technical price—is a response to a profitability signal that was distorted by the data quality at the point of selection. The pricing of unknown risk is amplified when the data the pricing depends on is non-standard.

What goes wrong when incomparable-submission growth is not governed?

When incomparable-submission growth is not governed, five financial failures emerge: the margin on the growth segments deteriorates, the return on capital falls below the target, the earnings guidance is missed, the portfolio's composition is skewed, and the CUO discovers the profitability drag when the loss ratio develops.

What do CFOs and CUOs actually need from the incomparable-submission profitability analysis?

CFOs and CUOs need an analysis that compares the profitability of standard-submission-sourced business to non-standard-submission-sourced business, quantifies the margin drag, and builds the investment case for standardisation.

Pranav is the CFO of a multi-line reinsurer. The CUO reported that the property line's growth had exceeded the target, but the line's loss ratio was deteriorating. The investigation revealed that sixty percent of the new business was sourced from brokers whose submissions used non-standard exposure definitions, and the pricing model had produced technical prices that were five percent below the prices the standard-submission comparison would have indicated.

Pranav built the profitability analysis: the margin drag on the non-standard-sourced business was three points of combined ratio, and the drag was reducing the line's ROE by the same amount. He used the analysis to build the investment case for a submission-standardisation platform, and the board approved the investment.

That is what every CFO should be calculating: what is the margin drag of the growth that incomparable submissions are funding?

• A comparison of the loss ratio and ROE for standard-sourced versus non-standard-sourced business. "For each line, calculate the loss ratio and ROE for business sourced from standard submissions and from non-standard submissions, and the difference is the data-quality margin drag."
• A growth-quality metric that measures the proportion of new business sourced from standard submissions. "Track the percentage of new business that meets the submission-data standard, and include it in the CUO's portfolio-quality dashboard."
• A pricing-model sensitivity to the submission-data quality. "Run the pricing model on the standard data and on the original non-standard data for the same risk, and calculate the pricing difference attributable to the data quality."
• A capital-allocation adjustment for growth funded by non-standard submissions. "Apply a conservatism haircut to the expected return for growth segments where the submission-data quality is below the standard."
• An investment case for submission standardisation, based on the margin-drag quantification. "The investment cost versus the margin preserved by the standardisation, presented to the board as a capital-allocation decision."
• A board-level summary of the submission-data quality's profitability impact. "Present the margin-drag analysis, the growth-quality metric, and the investment case to the board."
• A broker-level profitability analysis that identifies which brokers' submissions are associated with the highest margin drag. "Identify the brokers whose submissions produce the largest pricing discrepancies, and prioritise them for the standardisation programme."
• A quarterly review of the submission-data quality's financial impact as part of the underwriting-performance governance.
• A target for the standard-submission proportion of new business, included in the CUO's performance objectives.
• An annual review of the standardisation programme's return on investment, comparing the margin preserved to the investment cost.

How can CFOs and CUOs build the incomparable-submission profitability analysis?

By directing the actuarial function to calculate the margin drag, defining the growth-quality metric, building the investment case, and reporting the impact to the board.

What does the profitability analysis deliver in practice?

A CFO who can quantify the margin the portfolio is losing to incomparable submissions, an investment case the board can evaluate, and a growth strategy whose profitability is based on comparable data.

Return to Pranav. Two years after the standardisation platform was deployed, the non-standard-submission proportion of new business has been reduced from sixty percent to fifteen percent, and the margin drag has been reduced proportionally. The board's quarterly review now includes the submission-data-quality metric.

The broader financial reflection is that growth is only profitable if the data on which the growth decisions are based is comparable across the sources of growth, and incomparable data is a growth-quality risk that erodes the return on the capital deployed. The CFO who quantifies the drag quantifies the cost of the data inconsistency.

Conclusion

For CFOs and CUOs, broker submissions that cannot be compared are a profitability drag on the portfolio's growth, and the CFO who quantifies the drag—through the margin comparison, the growth-quality metric, and the investment case—quantifies the cost of the data inconsistency and builds the case for the standardisation that eliminates it.

About the author

Hitul Mistry is the Founder of Insurnest, an InsurTech company that engineers end-to-end technology exclusively for the insurance industry serving carriers, TPAs, MGAs, brokers, and reinsurers across India, the UAE, and the US. With more than a decade of insurance domain experience, he has built systems spanning underwriting automation, AI-powered underwriting intelligence, claims management, rating and quoting, broking and agency platforms, and reinsurance automation across Health/GMC, Group Life, Motor, P&C, and Reinsurance. Insurnest doesn't adapt generic software to insurance; it builds from the workflow up.

Connect with Hitul on LinkedIn.